A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

Ryotaro Nakamura; Corinna La Rosa; Dongyun Yang; Joshua A. Hill; Armin Rashidi; Hannah Choe; Qiao Zhou; Chetan Raj Lingaraju; Teodora Kaltcheva; Jeffrey Longmate; Jennifer Drake; Cynthia Slape; Lupe Duarte; Monzr M. Al Malki; Vinod A. Pullarkat; Ahmed Aribi; Steven Devine; Michael R. Verneris; Jeffrey S. Miller; Stephen J. Forman; Ibrahim Aldoss; Don J. Diamond

doi:10.3324/haematol.2023.284544

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

Ryotaro Nakamura
, Corinna La Rosa
, Dongyun Yang
, Joshua A. Hill
, Armin Rashidi
, Hannah Choe
, Qiao Zhou
, Chetan Raj Lingaraju
, Teodora Kaltcheva
, Jeffrey Longmate
, Jennifer Drake
, Cynthia Slape
, Lupe Duarte
, Monzr M. Al Malki
, Vinod A. Pullarkat
, Ahmed Aribi
, Steven Devine
, Michael R. Verneris
, Jeffrey S. Miller
, Stephen J. Forman

Ibrahim Aldoss, Don J. Diamond

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English (US)
Journal	Haematologica
DOIs	https://doi.org/10.3324/haematol.2023.284544
State	Published - 2024

PubMed: MeSH publication types

Clinical Trial, Phase II
Letter
Multicenter Study
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Publisher link

10.3324/haematol.2023.284544

Find It

Find It at U of M Libraries

Cite this

Nakamura, R., La Rosa, C., Yang, D., Hill, J. A., Rashidi, A., Choe, H., Zhou, Q., Lingaraju, C. R., Kaltcheva, T., Longmate, J., Drake, J., Slape, C., Duarte, L., Al Malki, M. M., Pullarkat, V. A., Aribi, A., Devine, S., Verneris, M. R., Miller, J. S., ... Diamond, D. J. (2024). A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant. Haematologica. https://doi.org/10.3324/haematol.2023.284544

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant. / Nakamura, Ryotaro; La Rosa, Corinna; Yang, Dongyun et al.
In: Haematologica, 2024.

Research output: Contribution to journal › Article › peer-review

Nakamura, R, La Rosa, C, Yang, D, Hill, JA, Rashidi, A, Choe, H, Zhou, Q, Lingaraju, CR, Kaltcheva, T, Longmate, J, Drake, J, Slape, C, Duarte, L, Al Malki, MM, Pullarkat, VA, Aribi, A, Devine, S, Verneris, MR, Miller, JS, Forman, SJ, Aldoss, I & Diamond, DJ 2024, 'A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant', Haematologica. https://doi.org/10.3324/haematol.2023.284544

@article{ec92afda04f04c32a596b04998efa086,

title = "A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant",

author = "Ryotaro Nakamura and \{La Rosa\}, Corinna and Dongyun Yang and Hill, \{Joshua A.\} and Armin Rashidi and Hannah Choe and Qiao Zhou and Lingaraju, \{Chetan Raj\} and Teodora Kaltcheva and Jeffrey Longmate and Jennifer Drake and Cynthia Slape and Lupe Duarte and \{Al Malki\}, \{Monzr M.\} and Pullarkat, \{Vinod A.\} and Ahmed Aribi and Steven Devine and Verneris, \{Michael R.\} and Miller, \{Jeffrey S.\} and Forman, \{Stephen J.\} and Ibrahim Aldoss and Diamond, \{Don J.\}",

year = "2024",

doi = "10.3324/haematol.2023.284544",

language = "English (US)",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

}

TY - JOUR

T1 - A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

AU - Nakamura, Ryotaro

AU - La Rosa, Corinna

AU - Yang, Dongyun

AU - Hill, Joshua A.

AU - Rashidi, Armin

AU - Choe, Hannah

AU - Zhou, Qiao

AU - Lingaraju, Chetan Raj

AU - Kaltcheva, Teodora

AU - Longmate, Jeffrey

AU - Drake, Jennifer

AU - Slape, Cynthia

AU - Duarte, Lupe

AU - Al Malki, Monzr M.

AU - Pullarkat, Vinod A.

AU - Aribi, Ahmed

AU - Devine, Steven

AU - Verneris, Michael R.

AU - Miller, Jeffrey S.

AU - Forman, Stephen J.

AU - Aldoss, Ibrahim

AU - Diamond, Don J.

PY - 2024

Y1 - 2024

UR - https://www.scopus.com/pages/publications/85185453788

UR - https://www.scopus.com/pages/publications/85185453788#tab=citedBy

U2 - 10.3324/haematol.2023.284544

DO - 10.3324/haematol.2023.284544

M3 - Article

C2 - 38328852

AN - SCOPUS:85185453788

SN - 0390-6078

JO - Haematologica

JF - Haematologica

ER -

A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this